<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Markatos C</submitter><funding>Operational Program Competitiveness, Entrepreneurship, and Innovation, under the call Research-Create-Innovate</funding><funding>NIDDK NIH HHS</funding><pagination>4127</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11397358</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(17)</volume><pubmed_abstract>The gonadotropin-releasing hormone (GnRH) receptor (GnRH-R) is highly expressed in ovarian cancer cells (OCC), and it is an important molecular target for cancer therapeutics. To develop a new class of drugs targeting OCC, we designed and synthesized Con-3 and Con-7 which are novel high-affinity GnRH-R agonists, covalently coupled through a disulfide bond to the DNA synthesis inhibitor mitoxantrone. We hypothesized that Con-3 and Con-7 binding to the GnRH-R of OCC would expose the conjugated mitoxantrone to the cellular thioredoxin, which reduces the disulfide bond of Con-3 and Con-7. The subsequent release of mitoxantrone leads to its intracellular accumulation, thus exerting its cytotoxic effects. To test this hypothesis, we determined the cytotoxic effects of Con-3 and Con-7 using the S</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells.</pubmed_title><pmcid>PMC11397358</pmcid><funding_grant_id>R01 DK122332</funding_grant_id><funding_grant_id>Τ2ΕΔΚ 02056</funding_grant_id><pubmed_authors>Komontachakis G</pubmed_authors><pubmed_authors>Liapakis G</pubmed_authors><pubmed_authors>Karageorgos V</pubmed_authors><pubmed_authors>Vlata Z</pubmed_authors><pubmed_authors>Venihaki M</pubmed_authors><pubmed_authors>Tselios T</pubmed_authors><pubmed_authors>Markatos C</pubmed_authors><pubmed_authors>Tsakalakis N</pubmed_authors><pubmed_authors>Biniari G</pubmed_authors><pubmed_authors>Chepurny OG</pubmed_authors><pubmed_authors>Holz GG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells.</name><description>The gonadotropin-releasing hormone (GnRH) receptor (GnRH-R) is highly expressed in ovarian cancer cells (OCC), and it is an important molecular target for cancer therapeutics. To develop a new class of drugs targeting OCC, we designed and synthesized Con-3 and Con-7 which are novel high-affinity GnRH-R agonists, covalently coupled through a disulfide bond to the DNA synthesis inhibitor mitoxantrone. We hypothesized that Con-3 and Con-7 binding to the GnRH-R of OCC would expose the conjugated mitoxantrone to the cellular thioredoxin, which reduces the disulfide bond of Con-3 and Con-7. The subsequent release of mitoxantrone leads to its intracellular accumulation, thus exerting its cytotoxic effects. To test this hypothesis, we determined the cytotoxic effects of Con-3 and Con-7 using the S</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-07-09T11:10:54.446Z</modification><creation>2025-04-04T11:35:56.567Z</creation></dates><accession>S-EPMC11397358</accession><cross_references><pubmed>39274973</pubmed><doi>10.3390/molecules29174127</doi></cross_references></HashMap>